面部烧伤后早期使用5-羟色胺能抗抑郁药与增生性瘢痕、代谢并发症及死亡率降低相关
本研究基于TriNetX美国协作网络2010–2025年成人面部二度或三度烧伤患者数据,将伤后1个月内处方抗抑郁药者与未使用者经倾向性评分匹配后比较。匹配后每组各3392例,抗抑郁药组增生性瘢痕和皮肤感染在各时间点均显著升高(P<.01),180天起乳酸酸中毒和高血糖升高(P<.05),但死亡率在各时间间隔均持续较低(P<.05)。
要点
- 面部烧伤后早期使用5-羟色胺能抗抑郁药与增生性瘢痕和皮肤感染风险升高相关。
- 该暴露与180天起乳酸酸中毒和高血糖风险升高相关。
- 该暴露与各时间间隔死亡率持续降低相关。
核心结论
- 面部烧伤后早期使用5-羟色胺能抗抑郁药与增生性瘢痕形成、感染和代谢紊乱风险增加相关,但死亡率降低。
研究设计与样本
- 基于TriNetX美国协作网络的回顾性队列研究,纳入2010–2025年成人面部二度或三度烧伤患者。
- 伤后1个月内处方抗抑郁药者与未使用者比较,按人口学、烧伤特征及精神与躯体合并症进行倾向性评分匹配。
- 匹配后每组各3392例,在90天、180天和1年评估结局,采用单因素回归分析,显著性定义为P<.05。
主要发现
- 匹配后抗抑郁药组增生性瘢痕和皮肤感染在各时间点均显著高于匹配对照组(P<.01)。
- 匹配后抗抑郁药组乳酸酸中毒和高血糖自180天起升高(P<.05)。
- 匹配后抗抑郁药组死亡率在各时间间隔均持续较低(P<.05)。
临床怎么用
- 面部烧伤后使用5-羟色胺能抗抑郁药的患者应加强瘢痕、感染及代谢指标的监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Facial burns can cause profound psychological distress, often treated with selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. While their psychiatric benefits are established, their impact on wound healing and long-term outcomes is less defined. This study examines associations between early serotonergic antidepressant exposure and physiological complications following facial burn injury. Adult patients with second- or third-degree facial burns (2010-2025) were identified in the TriNetX US Collaborative Network. Those prescribed antidepressants within one month of injury were compared to controls without antidepressant use. Propensity score-matching was performed based on demographics, burn characteristics, and psychiatric as well as medical comorbidities. Outcomes assessed at 90 days, 180 days, and 1 year included skin infection, hypertrophic scarring, lactic acidosis, hyperglycemia, hypoglycemia, and mortality. Univariate regression analyses were used to compare each outcome, with significance defined as P < .05. Of 46 971 facial burn patients identified, 3392 remained in each group after matching. Patients in the matched antidepressant group had significantly higher rates of hypertrophic scarring and skin infection at all time points compared to those in the matched control group (P < .01). Additionally, lactic acidosis and hyperglycemia became elevated beginning at 180 days (P < .05) among patients who were prescribed antidepressants. Mortality, however, was consistently lower in the matched antidepressant group at all time intervals (P < .05). Early serotonergic antidepressant use after facial burn injury is linked to increased risk of hypertrophic scar formation, infection, and metabolic disturbances, yet decreased rates of mortality.
引用
- Dao MQ, Vangal P, Montalmant KE, et al. Serotonergic Antidepressant Use After Recent Facial Burn Injury is Associated with Hypertrophic Scarring, Metabolic Complications, and Reduced Mortality. J Burn Care Res. 2026. PMID: 41065665. doi:10.1093/jbcr/iraf196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。